CAPTRUST Financial Advisors’s Maravai LifeSciences MRVI Stock Holding History

CAPTRUST Financial Advisors’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-38,129	Closed	-$250K	–	2458
2023 Q4	$250K	Buy	+38,129	New	+$246K	﹤0.01%	2234
2022 Q4	–	Sell	-30,036	Closed	-$767K	–	2138
2022 Q3	$767K	Sell	30,036 -4,937	-14%	-$124K	﹤0.01%	1052
2022 Q2	$994K	Buy	34,973 +1,438	+4%	+$45.6K	0.01%	841
2022 Q1	$1.18M	Buy	33,535 +442	+1%	+$14.8K	0.01%	783
2021 Q4	$1.39M	Buy	33,093 +12,545	+61%	+$508K	0.01%	681
2021 Q3	$1.01M	Buy	20,548 +11,129	+118%	+$543K	0.01%	747
2021 Q2	$393K	Buy	9,419 +3,108	+49%	+$120K	﹤0.01%	1102
2021 Q1	$225K	Buy	+6,311	New	+$209K	﹤0.01%	1392

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CAPTRUST Financial Advisors's MRVI Position: Q1 2024 in Review

CAPTRUST Financial Advisors sold out of Maravai LifeSciences (MRVI) in Q1 2024, closing a stake of 38,129 shares — an estimated $250K sold.

CAPTRUST Financial Advisors first reported a position in MRVI in Q1 2021 and held it in 8 quarters. The position peaked at $1.39M in Q4 2021. 210 funds tracked by Wall St. Rank hold MRVI as of Q1 2024.

CAPTRUST Financial Advisors reported no remaining Maravai LifeSciences position as of Q1 2024 after selling out during the quarter.
CAPTRUST Financial Advisors sold 38,129 Maravai LifeSciences shares in Q1 2024, an estimated $250K.
CAPTRUST Financial Advisors first reported a position in Maravai LifeSciences in Q1 2021 and held it in 8 quarters.
CAPTRUST Financial Advisors's Maravai LifeSciences position peaked at $1.39M in Q4 2021.
210 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2024.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2024, filed 15 May 2024.